Abstract: A pharmaceutical composition including a therapeutically effective amount of at least one oligomannoside produced by chemical synthesis which is homologous to a wall oligomannoside of an infectious organism or pathogen, or a derivative thereof, and a pharmaceutically acceptable vehicle.
Type:
Application
Filed:
August 1, 2006
Publication date:
November 30, 2006
Applicant:
Centre Hospitalier regional universitaire (CHRU)
Inventors:
Jacques Esnault, Pierre Sinay, Reynald Chevalier, Jean-Frederic Colombel, Jean-Maurice Mallet, Boualem Sendid, Thierry Jouault, Daniel Poulain, Pierre-Andre Trinel
Abstract: A pharmaceutical composition including a therapeutically effective amount of at least one oligomannoside produced by chemical synthesis which is homologous to a wall oligomannoside of an infectious organism or pathogen, or a derivative thereof, and a pharmaceutically acceptable vehicle.
Type:
Grant
Filed:
May 23, 2002
Date of Patent:
September 19, 2006
Assignee:
Centre Hospitalier Regional Universitaire (CHRU)
Inventors:
Jacques Esnault, Pierre Sinay, Reynald Chevalier, Jean-Frédéric Colombel, Jean-Maurice Mallet, Boualem Sendid, Thierry Jouault, Daniel Poulain, Pierre-André Trinel
Abstract: A pharmaceutical composition including a therapeutically effective amount of at least one oligomannoside produced by chemical synthesis which is homologous to a wall oligomannoside of an infectious organism or pathogen, or a derivative thereof, and a pharmaceutically acceptable vehicle.
Type:
Application
Filed:
May 23, 2002
Publication date:
June 5, 2003
Applicant:
Centre Hospitalier Regional Universitaire (CHRU)
Inventors:
Jacques Esnault, Pierre Sinay, Reynald Chevalier, Jean-Frederic Colombel, Jean-Maurice Mallet, Boualem Sendid, Thierry Jouault, Daniel Poulain, Pierre-Andre Trinel